Suven Pharmaceuticals Announces May 1, 2025 as Effective Date for Amalgamation of Cohance Lifesciences
Mumbai/Hyderabad, April 26, 2025: Suven Pharmaceuticals Limited (BSE: 543064, NSE: SUVENPHAR), a leading contract development and manufacturing organization (CDMO), announced that it has received final...
